Bethesda, MD - This FASEB Science Research Conference focuses on cutting-edge research how protease networks operating at the blood-tissue interface contribute to the regulation of blood coagulation, endothelial cell and vascular biology, tissue repair and remodeling, developmental processes, common inflammatory diseases, sepsis, diabetes and cancer. A panel of leading experts and young scientists will highlight emerging concepts about the biochemical control of protease- substrate interactions, major technological advances allowing structural studies of these protease-substrate interactions in their natural environment, and novel insights into the biological contexts in which these interactions take place. A major incentive for this meeting is to foster interdisciplinary interactions and collaborations for developing novel protease-centered drugs, and facilitating the deployment of protease-modulating drugs that have already entered clinical practice or are in advanced stages of clinical development as therapeutics for stroke, myocardial infarction, venous and arterial thrombosis, bleeding disorders, and related cardiovascular disease. This SRC conference has an outstanding track record for bringing together leaders from basic research, translational clinical research, and industry, and for promoting the recruitment of young scientists into this vigorously growing field of research on protease / protease-receptor structure and function.
FASEB has announced a total of 34 Science Research Conferences (SRC) in 2015. Registration opens January 20, 2015. For more information about an SRC, view preliminary programs, or find a listing of all our 2015 SRCs, please visit http://www.
Since 1982, FASEB SRC has offered a continuing series of inter-disciplinary exchanges that are recognized as a valuable complement to the highly successful society meetings. Divided into small groups, scientists from around the world meet intimately and without distractions to explore new approaches to those research areas undergoing rapid scientific changes.
FASEB is composed of 27 societies with more than 120,000 members, making it the largest coalition of biomedical research associations in the United States. Our mission is to advance health and welfare by promoting progress and education in biological and biomedical sciences through service to our member societies and collaborative advocacy.
Federation of American Societies for Experimental Biology
9650 Rockville Pike, Bethesda, MD 20814-3998
PROTEASES IN HEMOSTASIS AND VASCULAR BIOLOGY
Date: June 7-12, 2015, Keystone, Colorado
Organizers: Hartmut Weiler, José López